Explore All Access
Check if your research matches the topics covered in American Journal of Clinical Oncology: Cancer Clinical Trials?
- Degree of match
- Common matching concepts
- Additional journal recommendations
American Journal of Clinical Oncology: Cancer Clinical Trials : Impact Factor & More
eISSN: 1537-453XpISSN: 0277-3732
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Aims and Scope
The American Journal of Clinical Oncology is a bimonthly, peer-reviewed, scientific, oncology journal, published by Lippincott Williams & Wilkins. The editor in chief is David E. Wazer (Tufts University). The journal was formerly entitled Cancer Clinical Trials. Less
American Journal of Clinical Oncology: Cancer Clinical Trials Key Metrics
CiteScore 
5
SJR
Q3Oncology
SNIP
1.05
Topics Covered on American Journal of Clinical Oncology: Cancer Clinical Trials
Cancer
Chemoradiotherapy
Neuroendocrine tumors
Adjuvant
Overall survival
Breast cancer
Toxicity
Small cell
Colorectal cancer
Hepatocellular carcinoma
Multivariate analysis
Immunotherapy
Prostate cancer
Immune checkpoint inhibitors
Progression-free survival
Body mass index
Radiation oncology
Gastrointestinal infections
Triple-negative breast cancer
Systematic review
American Journal of Clinical Oncology: Cancer Clinical Trials Journal Specifications
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1982 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in American Journal of Clinical Oncology: Cancer Clinical Trials ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in American Journal of Clinical Oncology: Cancer Clinical Trials
Complications, Costs, and Health Care Resource Use with Tissue Biopsy Followed by Liquid Biopsy Versus Tissue Re-biopsy in Patients With Newly Diagnosed Metastatic Nonsmall-cell Lung Cancer.
- 5 Nov 2024
- American journal of clinical oncology
Evaluating N-acetylcysteine as a Protective Agent Against Chemotherapy-induced Neuropathy in Breast Cancer: A Triple-blind, Randomized Clinical Trial.
- 4 Nov 2024
- American journal of clinical oncology
Disparities in Receipt of Adjuvant Immunotherapy among Stage III Melanoma Patients.
- 1 Nov 2024
- American journal of clinical oncology
Disparities in Survival Outcomes Among Patients With Metastatic Melanoma in Texas: Implications for Policy and Interventions in the Era of Immune Checkpoint Inhibitors.
- 1 Nov 2024
- American journal of clinical oncology
The Effect of PD-1/PD-L1 Inhibitor and Statin Combination Therapy on Overall Survival and Gastrointestinal Toxicity.
- 30 Oct 2024
- American journal of clinical oncology
Safety and Efficacy of Neoadjuvant Docetaxel and Radiotherapy in Localized High-Risk Prostate Cancer: Results From a Prospective Pilot Study.
- 30 Oct 2024
- American journal of clinical oncology
Complications, Costs, and Health Care Resource Use with Tissue Biopsy Followed by Liquid Biopsy Versus Tissue Re-biopsy in Patients With Newly Diagnosed Metastatic Nonsmall-cell Lung Cancer.
- 5 Nov 2024
- American journal of clinical oncology
Evaluating N-acetylcysteine as a Protective Agent Against Chemotherapy-induced Neuropathy in Breast Cancer: A Triple-blind, Randomized Clinical Trial.
- 4 Nov 2024
- American journal of clinical oncology
Disparities in Receipt of Adjuvant Immunotherapy among Stage III Melanoma Patients.
- 1 Nov 2024
- American journal of clinical oncology
Disparities in Survival Outcomes Among Patients With Metastatic Melanoma in Texas: Implications for Policy and Interventions in the Era of Immune Checkpoint Inhibitors.
- 1 Nov 2024
- American journal of clinical oncology
The Effect of PD-1/PD-L1 Inhibitor and Statin Combination Therapy on Overall Survival and Gastrointestinal Toxicity.
- 30 Oct 2024
- American journal of clinical oncology
Safety and Efficacy of Neoadjuvant Docetaxel and Radiotherapy in Localized High-Risk Prostate Cancer: Results From a Prospective Pilot Study.
- 30 Oct 2024
- American journal of clinical oncology
Compare Similar Journals with American Journal of Clinical Oncology: Cancer Clinical Trials
Select Journals to Compare with American Journal of Clinical Oncology: Cancer Clinical Trials
Total journals - 9
You can select up to 3 Journals at a time
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Annals of Oncology
Publisher: ELSEVIER
Cancers
Publisher: MDPI
BMC Cancer
Publisher: BMC
Radiotherapy and Oncology
Publisher: ELSEVIER IRELAND LTD
European Journal of Cancer
Publisher: ELSEVIER SCI LTD
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Cancer Medicine
Publisher: WILEY
0 Journals Selected to compare with
American Journal of Clinical Oncology: Cancer Clinical Trials
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on American Journal of Clinical Oncology: Cancer Clinical Trials
How long has American Journal of Clinical Oncology: Cancer Clinical Trials been actively publishing? 
American Journal of Clinical Oncology: Cancer Clinical Trials has been in operation since 1982 till date.
What is the publishing frequency of American Journal of Clinical Oncology: Cancer Clinical Trials?
American Journal of Clinical Oncology: Cancer Clinical Trials published with a Monthly frequency.
How many articles did American Journal of Clinical Oncology: Cancer Clinical Trials publish last year?
In 2023, American Journal of Clinical Oncology: Cancer Clinical Trials publsihed 105 articles.
What is the eISSN & pISSN for American Journal of Clinical Oncology: Cancer Clinical Trials?
For American Journal of Clinical Oncology: Cancer Clinical Trials, eISSN is 1537-453X and pISSN is 0277-3732.
What is Citescore for American Journal of Clinical Oncology: Cancer Clinical Trials?
Citescore for American Journal of Clinical Oncology: Cancer Clinical Trials is 5.
What is SNIP score for American Journal of Clinical Oncology: Cancer Clinical Trials?
SNIP score for American Journal of Clinical Oncology: Cancer Clinical Trials is 1.05.
What is the SJR for American Journal of Clinical Oncology: Cancer Clinical Trials?
SJR for American Journal of Clinical Oncology: Cancer Clinical Trials is Q3.
Who is the publisher of American Journal of Clinical Oncology: Cancer Clinical Trials?
LIPPINCOTT WILLIAMS & WILKINS is the publisher of American Journal of Clinical Oncology: Cancer Clinical Trials.
